Safety and Efficacy of Kaletra in ARV Therapy Experienced Patients

Phase IV, Non Randomized Study in ARV Experienced Patients Under Switch Therapy With Kaletra

To demonstrate that patients treated with Kaletra have an improvement in their quality of life compared to the quality of life they had with their previous NRTI therapy.

Inclusion Criteria:

• HIV Infected subjects
• Subjects failing in current HIV treatment, or
• Subjects with a viral load < 400 copies/mL and not tolerating their current HIV treatment.

Exclusion Criteria:

• Subject is currently participating in another clinical study or has participated in another clinical study within 30 days prior to screening visit
• Subject is pregnant